Published on January 25, 2012

Richard Schierburg Begins Tenure as Chair of National Jewish Health Board of Directors

National Jewish Health welcomed new leadership on January, 25, 2012, as Richard A. Schierburg began his tenure as Chair of the Board of Directors. He succeeds outgoing chair, Thomas Gart, who will continue to serve on the Board.

“It has been an extraordinary and rewarding experience serving as board chair for National Jewish Health,” said  Mr. Gart. “I am happy to pass the gavel to the very capable hands of Rich Schierburg. With his energy, expertise, and knowledge of National Jewish Health, Rich will be an ideal leader during this remarkable time. ”

Schierburg, a veteran developer and investment broker, has founded several companies, including most recently Peregrine Group Development LLC, a land development, retail and multi-family development firm. He began his career as an investment broker at CB Richard Ellis. Schierburg earned a bachelor’s degree from Seattle University, and attended both Stanford University and University of Colorado Master of Business Administration programs.

Schierburg joined the National Jewish Health Board in 2004, and has served as chair of the institution’s Development Board, and as a member of the Executive, facilities and real estate committees. Schierburg is also board chair of Archdiocesan Housing, and  is a member of the Urban Land Institute, the International Council of Shopping Centers and the National Association of Industrial and Office Parks. Schierburg and his wife, Linda, have two grown children.

“As a Colorado native, I am proud to have such an incredible, nationally recognized healthcare institution in Denver, and am honored be taking on this leadership for the institution,” said Schierburg. “I look forward to an exciting and productive chapter in the evolution of National Jewish Health.”

Gart, president of The Gart Companies, joined the Board of Directors in 1995, and was appointed Chair in 2009. Previously he had served on the Finance and Investment committees. Mr. Gart will remain on the board, serving on the executive committee and leading capital fundraising efforts.

“Tom Gart has been an outstanding board chair, leading National Jewish through a period of tremendous growth and major achievements in the execution of our 10-year Strategic Plan,” said Michael Salem, MD, President and CEO of National Jewish Health. “We are grateful for the support our voluntary board members and trustees provide to the institution.  We could not continue to be the #1 respiratory hospital in the nation without the leadership provided by people like Tom Gart and Rich Schierburg.”